Insights
Explore Resources
Access webinars, technical articles, white papers, and industry insights designed to support informed decision-making.
Featured Insights
Explore technical resources and industry perspectives
Access curated content designed to support informed decisions across drug delivery, packaging, and patient-centered innovation.
WHITE PAPER
Double Sterilization in Pharmaceuticals: The Impact of Annex 1 on Component Strategy
Since the 2022 revision of EU GMP Annex 1 came into effect in August 2023, sterile manufacturing strategy has become one of the most consequential decisions in injectable drug development. What was once a binary choice between aseptic processing and terminal sterilization is shifting toward a hybrid "double sterilization" model — purchasing pre-sterilized, ready-to-use elastomeric components and then applying terminal sterilization again after filling and final assembly.
TECHNICAL ARTICLE
Lyophilization is growing in pharma, but technical challenges persist
In this technical article, Datwyler's Camille Ermine explores how lyophilization is reshaping pharmaceutical packaging decisions for biologics, mRNA therapeutics, ADCs, and orphan drugs — covering stopper geometry, moisture control, container closure integrity, and extractables and leachables risk, and how the right component choices help manufacturers navigate the fill-finish challenges that come with freeze drying.
TECHNICAL ARTICLE
The evolving landscape of subcutaneous drug administration
In the new subcutaneous drug delivery landscape, the growing trend towards patient-friendly, at-home administration is driving demand for larger volume packaging formats. How is the industry and its supply chain responding?
Upcoming Events
Connect with Datwyler Healthcare at industry-leading events
CONFERENCE
Festival of Biologics
Datwyler joins the biologics community in Basel for three days of scientific exchange, innovation showcasing, and strategic discussion on the future of biologic drug development and delivery. Our team engages with biotech and biopharma leaders to explore how purpose-built container closure systems — from silicone-free components to ready-to-use formats — support the integrity and stability of sensitive biologic molecules.
PRESENTATION
PODD Conference
Datwyler participates in the Parenteral and Ocular Drug Delivery Conference, engaging with specialists in drug delivery device design, combination products, and advanced injection systems. Our experts are available to discuss how Datwyler's elastomer components and closure systems integrate seamlessly into auto-injectors, wearable devices, and on-body delivery platforms for subcutaneous and parenteral applications.
CONFERENCE
PDA's Asia-Pacific Aseptic Processing of Biopharmaceuticals Conference
Datwyler attends PDA's Asia-Pacific biopharmaceuticals conference, joining industry leaders focused on aseptic manufacturing quality, contamination control, and container closure integrity. Our team shares expertise in ready-to-use component formats, sterilization validation, and elastomer performance — supporting biopharma manufacturers across the region in achieving the highest standards of aseptic processing.
